If you feel your psoriasis treatment is not producing what you seek here are 10 key factors that might be hindering your ...

Horsham: Johnson & Johnson is seeking the U.S. Food and Drug Administration (FDA) approval for the expansion of STELARA (ustekinumab) for the treatment of children two years and older ...

The FamilyPso questionnaire revealed caregiver burden among partners and family members of patients with psoriasis, which ...

ABOUT 5.7 MILLION men could have an autoimmune disease, according to a 2024 study published in the Journal of Clinical ...

To evaluate this, the authors systematically reviewed 14 studies involving a total of 169 patients (mean age 46.8 years), 74% ...

This link between central fat and ... Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Landmark resolution at the 78th WHA recognizes skin diseases as a global public health priority, urging action worldwide.

Alongside the data in PsA, UCB will present at EULAR new results demonstrating that Bimzelx delivered sustained clinical ...

Celltrion announces US FDA approval of additional presentation of Steqeyma, expanding dosing options for paediatric patients: Incheon, South Korea Tuesday, June 17, 2025, 16:00 Hr ...